Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check6 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed ('No longer looking for participants'). The page also introduces or updates several help and navigation sections, standardizes the Intervention/Treatment heading, and updates the revision tag to v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This appears to be a minor software update with no visible changes to study details or content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study status on the page is updated to Completed and results are posted, including 6-month tumor response data (PR/SD/PD) and survival outcomes (DFS and OS). A PDF of the Study Protocol and Statistical Analysis Plan was added to the Study Documents.SummaryDifference3%

- Check92 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No changes to the trial details or visible content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.